We do note, however, in some regions a nonsignificant trend towards higher mortality among female YPHIV aged 20 to 24 years compared with YNPHIV of the same age and sex (Table 3 ).
← all excerpts
Age-specific mortality rate ratios in adolescents and youth aged 10-24 years living with perinatally versus nonperinatally acquired HIV.
1
—
—